Abstract:Maria Clarissa Wiraputranto, 1 Irma Bernadette S Sitohang, 1 Adhimukti Tathyahita Sampurna, 1 Muhammad Ilyas 2 1 Department of Dermatology and Venereology, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Central General Hospital, Jakarta, Indonesia; 2 Department of Community Medicine, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia Correspondence: Irma Bernadette S Sitohang, Department of Dermatology and Venereology, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Central General Hospital, Jakarta, Indonesia, 10430, Tel +62818130761, Email Purpose: To evaluate the effectiveness of standard therapy for acne vulgaris based on Indonesian guidelines. Patients and Methods: New patients with acne vulgaris at Dr. Cipto Mangunkusumo National Central General Hospital, the national referral center in Indonesia, who met the criteria were included in this study. Patients were treated with standard therapy for acne vulgaris based on the 2017 guidelines of Dr. Cipto Mangunkusumo Hospital, depending on severity. Changes in the number of non-inflammatory, inflammatory, and total lesions and the proportion of acne severity after three months of therapy were analyzed retrospectively. Results: Among the 131 subjects, 63.4% had moderate acne; 20.6% had mild acne, and 16% had severe acne at baseline. Most patients (29 (22.2%)) received a combination of retinoic acid, benzoyl peroxide, and topical or oral antibiotics. Standard therapies reduced the median of non-inflammatory (25 (5– 135) vs 8 (0– 53)), inflammatory (10 (0– 93) vs 2 (0– 22)), and total lesions (41 (10– 160) vs 10 (1– 71)) at week 12 (all p < 0.001). The proportion of acne severity differed significantly after three months, with an increasing proportion of mild acne (20.6% vs 93.1%) and a decreasing percentage of moderate and severe acne (moderate = 63.6% vs 6.1%; severe, 16% vs 0.8%; p < 0.001). Conclusion: Standard therapy for acne vulgaris based on the clinical practice guidelines in Indonesia improved acne lesions and severity after 12 weeks. These results support the implementation of national guidelines for acne management in Indonesia, with the practice of improving antimicrobial stewardship. Keywords: acne vulgaris, clinical practice guideline, therapy, Indonesia, effectiveness Acne vulgaris (AV) is a prevalent chronic inflammatory disorder of the pilosebaceous unit affecting all ages, especially teenagers and young adults, leading to depression and anxiety in more severe cases. 1 It is the third most frequent dermatological cases at the Central and Regional General Hospital in Indonesia. 2 The incidence of AV constituted about 46% of the total new cases at Dr. Cipto Mangunkusumo National Central General Hospital's Cosmetic Dermatology clinic, with over 50% of moderate-to-severe acne. Effective and timely treatment of acne is needed to hasten skin resolution, prevent the formation of new acne and permanent scars, and alleviate the associated psychosocial burden. 1–3 AV management has been challenging because of various diagnostic parameters and treatment options globally accommodating each nation's condition. 3,4 Several acne guidelines are available in Indonesia, such as the consensus of the Indonesian Acne Expert Meeting (IAEM) in 2015 2 , clinical practice guidelines (CPGs) of the Indonesian Society of Dermatology and Venereology (INSDV) 5 and Dr. Cipto Mangunkusumo Hospital 6 in 2017, which have similarities in the recommended treatment choices. These national guidelines emanate from the best available evidence and relevant international guidelines with some adjustments; however. 3 To the best of our knowledge, there are no data on the effectiveness of standard therapy for AV based on the national guidelines to date. This study analyzed medical records from 2017 to 2019, as there was a COVID-19 pandemic from 2020 to 2021, thus hindering routine follow-up. The AV guideline in this research referred to the one by Dr. Cipto Mangunkusumo Hospital 2017 in line with the date of outpatient visits, for which therapy was based on this CPG. This paper presents the clinical outcomes of standard regimens in the national guidelines. This retrospective observational study was conducted using medical records from a national referral hospital in Indonesia. Data of new patients diagnosed with AV in the dermatology outpatient clinic between 2017 and 2019 were extracted. Cases were selected based on the inclusion and exclusion criteria of the total sampling technique. The minimum sample size was determined using the following formula: n = ( × p × q)/d 2 , where z = 1 -Abstract Truncated-

Effectiveness and Safety of a Dermocosmetic Cream as an Adjunct to Adapalene for Mild and Moderate Acne in Indonesia: Results of a Multicenter Randomized Controlled Study

A Multicentre, Randomized, Single-Blind Comparison of Topical Clindamycin 1%/benzoyl Peroxide 5% Once-Daily Gel Versus Clindamycin 1% Twice-Daily Gel in the Treatment of Mild to Moderate Acne Vulgaris in Chinese Patients.

Isotretinoin Erythromycin Gel in the Treatment of Acne Vulgaris: a Multicenter Randomized Parallel-Controlled Clinical Study

Investigating the Use of 0.3% Adapalene/2.5% Benzoyl Peroxide Gel for the Management of Moderate-to-Severe Acne in Indian Patients: A Phase 4 Study Assessing Safety and Efficacy

Efficacy of ceramides and niacinamide‐containing moisturizer versus hydrophilic cream in combination with topical anti‐acne treatment in mild to moderate acne vulgaris: A split face, double‐blinded, randomized controlled trial

Efficacy and Tolerability of a Sunscreen Containing Licochalcone a and L-Carnitine as an Adjunct to Retinoids in the Management of Acne and Post-Acne Pigmentation Among Malaysian Patients

Investigation of the effect of adapalene 0.3%/benzoyl peroxide 2.5% gel in Korean patients with acne: a randomized, double-blind clinical trial, with a histopathological and immunohistochemical study

Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study

Safety and Efficacy of Fixed-Dose Combination of Adapalene and Benzoyl Peroxide in Acne Vulgaris Treatment: A Systematic Review of Clinical Trials

Efficacy and safety of a cream containing octyl salicylic acid, salicylic acid, linoleic acid, nicotinamide, and piroctone olamine combined with 5% benzoyl peroxide in the treatment of acne vulgaris: a randomized controlled study

Comparing the Efficacy of Topical 4% Benzoyl Peroxide Versus Topical 0.1% Adapalene for Treatment of Acne Vulgaris in Skin of Color Population: A South Asian Perspective

The usefulness of a dermocosmetic containing Myrtus communis extract and azelaic acid for maintenance phase of adult female acne: Results from a randomized exploratory investigator‐blinded comparative study

Digital videography assessment of patients' experiences using adapalene-benzoyl peroxide gel in the treatment of acne vulgaris

2% supramolecular salicylic acid hydrogel vs. adapaline gel in mild to moderate acne vulgaris treatment: A multicenter, randomized, evaluator-blind, parallel-controlled trial

A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%

A survey assessing the role of a fixed-dose combination of 0.3% adapalene with 2.5% benzoyl peroxide in acne vulgaris

Long-Term Effectiveness and Safety of Up to 48 Weeks' Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne

Patient-Reported Outcomes in Acne Patients With Skin of Color Using Adapalene 0.3%-Benzoyl Peroxide 2.5%: A Prospective Real-World Study

Effectiveness of Standard Therapy for Acne Vulgaris Based on Clinical Practice Guidelines in Indonesia

Effects on the prevention of 0.1% adapalene gel maintenance treatment and relieving relapse of acne vulgaris:a multi-center, randomized controlled clinical trial

Efficacy and Tolerability of a Novel Cosmetic and Over‐the‐Counter Facial Acne Regimen Versus a Prescription Treatment